Both in Pharmaceuticals
Alkermes vs Oruka Therapeutics
Over the past year ALKS returned +51.0% and ORKA returned +269.7%; their daily moves had a correlation of 0.27.
ALKS +51.0% ORKA +269.7%Growth of $1, one year, split-adjusted
| Metric | ALKS | ORKA |
|---|---|---|
| Price | $45.89 | $101.41 |
| Market cap | $7.70B | $6.71B |
| Today | +0.44% | +1.87% |
| 1 month | +10.2% | +26.5% |
| 6 months | +29.9% | +45.3% |
| Year to date | +64.0% | +234.6% |
| 1 year | +52.1% | +287.2% |
| Revenue growth (YoY) | +21.8% | — |
| Gross margin | 80.4% | — |
| Net margin | 3.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.4× | — |
| Net cash | -$742.3M | $873.6M |
| Dividend yield | — | — |
| Volatility (60d) | 31.7% | 51.8% |
| Short % of float | 11.5% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).